Search Results

Pharmaceutical Company CEO Warned By FDA For Off-Label Marketing of Cholesterol Lowering Drug November 12, 2013 When a new drug is going to be introduced to the market, it must first be meticulously tested so that the U.S. Food and Drug Administration (FDA) can decide on what conditions the medication should be approved to treat. The Drug Injury Lawyers with Ferrer Poirot Feller explain that due to a (more...)